Loading
A trial approved by a qualified ethics committee in one country would not need to repeat the full review in another; the second country would accept the first review and check only local issues.
Building on the EU Clinical Trials Regulation single-assessment model and the US single-IRB requirement, a treaty or regulatory reliance agreement would allow ethics committees in participating countries (EU, UK, Switzerland, Canada, Australia, Japan) to rely on a lead committee's scientific and ethical assessment, with local review limited to consent language, insurance and site suitability.
Shares EU Clinical Trials Register / CTIS, Regulatory divergence between regions, Trials enrol too few, too slowly.
Shares EU Clinical Trials Register / CTIS, Regulatory divergence between regions, Trials enrol too few, too slowly.
Shares EU Clinical Trials Register / CTIS, Trials enrol too few, too slowly.
Shares EORTC, Trials enrol too few, too slowly.
Shares EU Clinical Trials Register / CTIS, Regulatory divergence between regions.
Shares Regulatory divergence between regions, Trials enrol too few, too slowly.
Shares EORTC, Trials enrol too few, too slowly.
Shares European Society for Medical Oncology (ESMO), Trials enrol too few, too slowly.